Adagene Reports Full Year 2020 Financial Results and Provides Corporate Updates
- Successfully completed Initial Public Offering raising approximately US$161 million in gross proceeds--Reported clinical data for anti-CD137 and two anti-CTLA-4...
Month: March 2021
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology BridgeBio, through...
ProMIS Neurosciences Announces Fiscal Year 2020 Results
TORONTO and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS or the...
Total number of shares and voting rights in Zealand Pharma at March 31, 2021
Company announcement – No. 18/ 2021 Total number of shares and voting rights in Zealand Pharma at March 31, 2021...
Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement
Appoints George Steinbrenner IV to its Board of DirectorsCHICAGO, March 31, 2021 (GLOBE NEWSWIRE) -- Wesana Health Inc. (“Wesana” or...
Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma
Based on Preliminary Data, FOCUS Trial Achieves Prespecified Success Threshold Conference Call Today at 8:00am Eastern Time NEW YORK, March...
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology
- BridgeBio, through its affiliate QED (“BridgeBio”), and Helsinn to co-commercialize infigratinib for oncology and all other indications other than...
Flexion Therapeutics Announces First Patient Treated in FX301 Phase 1b Trial for Management of Post-Operative Pain
FX301 is a locally administered NaV1.7 inhibitor (funapide) formulated for extended release in a proprietary thermosensitive hydrogelProof-of-concept trial will evaluate...
Natural Colors transaction closed
Divestment of Natural Colors to EQT closed as of March 31, 2021 Chr. Hansen Holding A/S and EQT today announced...
MediPharm Labs Reports Fourth Quarter and Full Year 2020 Results
BARRIE, Ontario, March 31, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or...
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
Notice of Allowance Grants Protection for Deriving Exosomes from Brown AdipocytesMELVILLE, N.Y., March 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
Microbix Announces Annual and Special Meeting Voting Results
MISSISSAUGA, Ontario, March 31, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a...
OncoResponse Raises $40.6 Million Series C Financing
- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures...
Better Choice Company Reports Fourth Quarter and Full Year 2020 Financial Results
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQX: BTTR) (the “Company” or “Better Choice”), an...
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease
NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
Cara Therapeutics to Host Virtual Research and Development Event on April 7, 2021
STAMFORD, Conn., March 31, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and...
CareDx Enhances Leadership Team with Key Appointments
CareDx Builds for the Future by Investing in TalentSOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:...
Analytica Announces Expansion of PeriCoach® Pelvic Health Solution into China
PeriCoach Pelvic floor exercise system for the treatment of stress urinary incontinence PeriCoach will be distributed through extensive network of...
Augmedix Reports Fourth Quarter and Full Year 2020 Financial Results
SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of remote medical documentation...
ONCOTELIC THERAPEUTICS, INC. ANNOUNCES PRESENTATION AT AYURVEDIC PERSPECTIVES ON COVID-19.
AGOURA HILLS, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC) (f/k/a Mateon Therapeutics,...